CX‐397: A Novel Antithrombotic Recombinant Hirudin Analog
2000; Wiley; Volume: 18; Issue: 1 Linguagem: Inglês
10.1111/j.1527-3466.2000.tb00032.x
ISSN1527-3466
AutoresYasuhiko Komatsu, Yoshifumi Inoue, Masashi Sasaki, S. Misawa, Haruo Takaku, Hideya Hayashi,
Tópico(s)Acute Myocardial Infarction Research
ResumoCardiovascular Drug ReviewsVolume 18, Issue 1 p. 47-60 Free Access CX-397: A Novel Antithrombotic Recombinant Hirudin Analog Yasuhiko Komatsu, Yasuhiko Komatsu Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorYoshifumi Inoue, Yoshifumi Inoue Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorMasashi Sasaki, Masashi Sasaki Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorSatoru Misawa, Satoru Misawa Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorHaruo Takaku, Haruo Takaku Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorHideya Hayashi, Corresponding Author Hideya Hayashi Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanAddress correspondence and reprint requests to: Dr. Hideya Hayashi, Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, 3-17-35 Niizo-Minami, Toda-shi, Saitama 335-8502, Japan. Fax: +81 (48) 443-1605. E-mail: hhayashi@j-energy.co.jpSearch for more papers by this author Yasuhiko Komatsu, Yasuhiko Komatsu Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorYoshifumi Inoue, Yoshifumi Inoue Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorMasashi Sasaki, Masashi Sasaki Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorSatoru Misawa, Satoru Misawa Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorHaruo Takaku, Haruo Takaku Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanSearch for more papers by this authorHideya Hayashi, Corresponding Author Hideya Hayashi Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama, JapanAddress correspondence and reprint requests to: Dr. Hideya Hayashi, Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, 3-17-35 Niizo-Minami, Toda-shi, Saitama 335-8502, Japan. Fax: +81 (48) 443-1605. E-mail: hhayashi@j-energy.co.jpSearch for more papers by this author First published: 07 June 2006 https://doi.org/10.1111/j.1527-3466.2000.tb00032.xCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume18, Issue1March 2000Pages 47-60 ReferencesRelatedInformation
Referência(s)